Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial Carcinoma
NCT06235268 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-01-31
Summary
Prospective and multicenter Italian registry intended for naïve adult patients affected by locally advanced-metastatic urothelial carcinoma intended for systemic treatment, or for palliative or observation procedures
Conditions
- Carcinoma, Urothelial
Interventions
- OTHER
-
Active systemic or non-systemic treatment (palliative or observation procedure)
The study includes medical visits and clinical-radiological re-evaluations according to clinical practice. The clinician will establish the number of visits necessary for each patient according to the needs encountered and depending on the treatment chosen.
Sponsors & Collaborators
-
Federation of Italian Cooperative Oncology Groups
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-23
- Primary Completion
- 2025-11-30
- Completion
- 2025-11-30
Countries
- Italy
Study Locations
More Related Trials
-
Multicentric Prospective T1 Urinary Bladder Cancer Registry
NCT05792033 ·Status: RECRUITING
-
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome
NCT04625556 ·Status: RECRUITING
-
Predictive Role of Microbiome in Patients With Urothelial Carcinoma
NCT06675656 ·Status: NOT_YET_RECRUITING
-
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
NCT06138561 ·Status: RECRUITING
-
SOGUG-AVELUMAB_RWD
NCT05700344 ·Status: COMPLETED
-
Evaluation of Clinical Outcomes, Tolerability, and Costs of Avelumab Maintenance and Pembrolizumab Second-Line Therapy in Advanced Urothelial Cancer.
NCT07207928 ·Status: COMPLETED
-
Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project
NCT05357768 ·Status: RECRUITING
-
Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
NCT06992986 ·Status: RECRUITING
-
To Detect the Sensitivity of the UroMark Assay
NCT02781428 ·Status: COMPLETED
-
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
NCT05874921 ·Status: RECRUITING
-
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
NCT06167356 ·Status: RECRUITING
-
DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.
NCT06820255 ·Status: RECRUITING ·Phase: PHASE4
-
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
NCT03413982 ·Status: RECRUITING
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
NCT06982794 ·Status: RECRUITING
-
Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma
NCT06663735 ·Status: NOT_YET_RECRUITING
-
AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
NCT05002556 ·Status: RECRUITING
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Pre-operative Immuno-Nutrition in Radical Cystectomy
NCT06355518 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Registry for Treatment of Upper Urinary Tract Tumours
NCT02281188 ·Status: UNKNOWN
-
First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma
NCT03324282 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Collection of Samples for Urothelial Cancer of Bladder
NCT04167332 ·Status: NOT_YET_RECRUITING
-
Detecting Bladder Cancer Using the UroMark Test.
NCT02676180 ·Status: COMPLETED
-
Prospective Sample Collection for Cancer of Bladder
NCT03973671 ·Status: RECRUITING
-
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
NCT06310759 ·Status: RECRUITING